Table 3.
Univariate analysis of the correlation between clinicopathological parameters and disease free survival time of HCC patients.
| Variable | Mean survival time (m) | 95% CI | P |
|---|---|---|---|
| Gender | |||
| Male | 32.256 | 20.793–43.719 | 0.843 |
| Female | 28.854 | 24.038–33.669 | |
| Age at surgery (yeas) | |||
| ≤60 | 30.910 | 25.438–36.382 | 0. 319 |
| >60 | 22.316 | 17.729–26.902 | |
| Tumor size (cm) | |||
| ≤5 | 33.435 | 26.636–40.234 | 0.120 |
| >5 | 24.766 | 19.587–29.945 | |
| HbsAg | |||
| Negative | 29.906 | 25.081–34.731 | 0. 307 |
| Positive | 20.632 | 15.972–25.291 | |
| Cirrhosis | |||
| No | 29.291 | 24.689–33.893 | 0.755 |
| Yes | 23.600 | 18.195–29.005 | |
| Child-Pugh | |||
| A | 29.791 | 25.287–34.294 | 0.034 |
| B | 12.667 | 4.671–20.662 | |
| AFP (ng/ml) | |||
| ≤20 | 32.007 | 30.650–43.410 | 0.127 |
| >20 | 28.649 | 23.388–33.910 | |
| Degree of differentiation | |||
| Well/moderate | 32.825 | 27.433–38.217 | 0.013 |
| Poor and not | 18.965 | 13.862–24.069 | |
| TNM stage | |||
| I/II | 39.352 | 32.666–46.038 | 0.000 |
| III/IV | 16.549 | 13.397–19.701 | |
| RBP2 expression | |||
| Negative | 47.323 | 38.148–56.228 | 0.000 |
| Positive | 22.140 | 17.965–26.315 | |